| Sickle Cell Disease - Stroke Prevention in Nigeria Trial (NCT01801423) | Vanderbilt University Medical Center | 2013-04-24 |
| Implication of the Oxydative Stress in the Pathophysiology of Sickle Cell Anemia: (NCT03368924) | Centre Hospitalier Universitaire de la Guadeloupe | 2013-04-09 |
| N-Acetylcysteine in Patients With Sickle Cell Disease (NCT01849016) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2013-04-01 |
| A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (SCD) (NCT01794000) | Eli Lilly and Company | 2013-04-01 |
| A Pilot Study of N-acetylcysteine in Patients With Sickle Cell Disease (NCT01800526) | Bloodworks | 2013-03-01 |
| CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation (NCT01966367) | Diane George | 2013-03-01 |
| Microvascular and Fibrosis Imaging Study (NCT01758250) | Duke University | 2013-02-01 |
| Implications of a Paediatrician-psychologist Tandem for Sickle Cell Disease Care and Impact on Cognitive Functioning (NCT03975699) | Fondation Ophtalmologique Adolphe de Rothschild | 2013-02-01 |
| Safety, Pharmacokinetic, and Pharmacodynamic Study of NKTT120 in Adult Patients With Stable Sickle Cell Disease (SCD) (NCT01783691) | NKT Therapeutics | 2013-02-01 |
| Intranasal Fentanyl Versus Intravenous Morphine in the Treatment of Severe Painful Sickle Cell Crises in Children (NCT03682211) | University College Dublin | 2012-12-12 |
| Losartan for Sickle Cell Kidney Disease (NCT01989078) | Emory University | 2012-12-01 |
| Single-center Prospective Evaluation of Sickle Cell Patient Care in the CHU Brugmann Emergency Department (NCT02386657) | Brugmann University Hospital | 2012-11-01 |
| The Use of Warmed Saline in Vaso-occlusive Episodes (NCT02316366) | Nationwide Children's Hospital | 2012-11-01 |
| Evaluation of Spectra Optia Red Blood Cell Exchange in Sickle Cell Patients (NCT01736657) | Terumo BCT | 2012-11-01 |
| Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators (NCT02197845) | Virginia Commonwealth University | 2012-10-01 |
| Cognitive Rehabilitation in Sickle Cell Disease (NCT01793740) | Duke University | 2012-10-01 |
| Parent Willingness to Participate in Tobacco Trials in the Pediatric Clinical Setting (NCT01673243) | St. Jude Children's Research Hospital | 2012-09-01 |
| Vascular Function Intervention Trial in Sickle Cell Disease (NCT01718054) | London School of Hygiene and Tropical Medicine | 2012-08-01 |
| Study of Decitabine and Tetrahydrouridine (THU) in Patients With Sickle Cell Disease (NCT01685515) | Yogen Saunthararajah | 2012-08-01 |
| Microvascular Blood Flow in Sickle Cell Anemia (NCT01566890) | Versiti Blood Health | 2012-07-01 |
| Effects of HQK-1001 in Patients With Sickle Cell Disease (NCT01601340) | HemaQuest Pharmaceuticals Inc. | 2012-07-01 |
| Use of a Mobile-based App for SCD Patients (NCT01833702) | Duke University | 2012-06-01 |
| A Single Dose Study of the Safety, Blood Levels and Biological Effects of Aes-103 Compared to Placebo in Subjects With Stable Sickle Cell Disease (NCT01597401) | Baxalta now part of Shire | 2012-05-12 |
| Study of Biological Markers in Children With Sickle Cell Disease (NCT04839159) | Queen Fabiola Children's University Hospital | 2012-05-10 |
| The Feasibility of Text Messaging to Assess Secondhand Smoke Exposure Among Youngsters With Cancer or Sickle Cell Disease (NCT01591187) | St. Jude Children's Research Hospital | 2012-05-01 |
| Blood Flow and Pain Crises in People With Sickle Cell Disease (NCT01568710) | National Heart, Lung, and Blood Institute (NHLBI) | 2012-03-21 |
| Adolescent, Caregiver, and Young Adult Perspectives of the Transition From Pediatric to Adult Care for Sickle Cell Disease: A Preliminary Evaluation of the Sickle Cell Disease Transition Program (NCT01569971) | St. Jude Children's Research Hospital | 2012-03-01 |
| Bone Marrow Transplantation in Young Adults With Severe Sickle Cell Disease (NCT01565616) | Emory University | 2012-03-01 |
| Heart Arteries and Sickle Cell Disease / Coeur Artères DREpanocytose (NCT03114137) | Cardiologie et Développement | 2012-03-01 |
| Multicenter Observational Study on Myocardial Iron Overload in 3 Multitransfused Populations (NCT01911871) | Assistance Publique - Hôpitaux de Paris | 2012-03-01 |
| A Study of Varespladib Infusion in Subjects With Sickle Cell Disease. (NCT01522196) | Anthera Pharmaceuticals | 2012-02-01 |
| Effect of Simvastatin Treatment on Vaso-occlusive Pain in Sickle Cell Disease (NCT01702246) | UCSF Benioff Children's Hospital Oakland | 2012-02-01 |
| Effects of Transfusion of Older Stored Red Cells (NCT01534676) | Columbia University | 2012-02-01 |
| Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron Overload (NCT01511848) | Ain Shams University | 2012-02-01 |
| Carbon Monoxide Levels and Sickle Cell Disease Severity (NCT01547793) | National Heart, Lung, and Blood Institute (NHLBI) | 2012-01-26 |
| Safety Study of MP4CO in Adult Sickle Cell Patients (NCT01356485) | Sangart | 2012-01-01 |
| Functional Neuroimaging of Pain Using EEG and fMRI (NCT02212691) | University of Minnesota | 2012-01-01 |
| Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease (NCT01461837) | New York Medical College | 2012-01-01 |
| Vitamin D for Sickle-cell Respiratory Complications (NCT01443728) | Gary M Brittenham, MD | 2011-12-13 |
| Ph I/II Study of Allogeneic SCT for Clinically Aggressive Sickle Cell Disease (SCD) (NCT01499888) | University of Illinois at Chicago | 2011-11-11 |
| A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (NCT01476696) | Eli Lilly and Company | 2011-11-01 |
| Improving Emergency Department Management of Adults With Sickle Cell Disease (NCT01603160) | Duke University | 2011-09-01 |
| A Relative Bioavailability Study of a Prasugrel Orally Disintegrating Tablet (NCT01430091) | Eli Lilly and Company | 2011-09-01 |
| CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant (NCT01049854) | New York Medical College | 2011-09-01 |
| Nitric Oxide and Sickle Cell Pain (NCT01393847) | National Institute of Nursing Research (NINR) | 2011-06-17 |
| Patient-Provider Tools to Improve the Transition to Adult Care in Sickle Cell Disease (NCT02200510) | Children's Hospital Medical Center, Cincinnati | 2011-06-01 |
| Stem Cell Transplantation for Sickle Cell Anemia (NCT01877837) | Hackensack Meridian Health | 2011-06-01 |
| Decitabine for High-Risk Sickle Cell Disease (NCT01375608) | National Heart, Lung, and Blood Institute (NHLBI) | 2011-06-01 |
| Molecular Phenotyping of Asthma in Sickle Cell Disease (NCT01879592) | Nemours Children's Clinic | 2011-06-01 |
| Treatment of Sickle Cell Patients Hospitalized in Pain Crisis With Prophylactic Dose Low-molecular-weight Heparin (LMWH) Versus Placebo (NCT01419977) | Duke University | 2011-05-01 |
| A Study of HQK-1001 in Patients With Sickle Cell Disease (NCT01322269) | HemaQuest Pharmaceuticals Inc. | 2011-04-01 |
| Topical Sodium Nitrite for Chronic Leg Ulcers in Adult Patients With Blood Disorders (NCT01316796) | National Heart, Lung, and Blood Institute (NHLBI) | 2011-03-15 |
| High-Tc Susceptometer to Monitor Transfusional Iron Overload (NCT01241357) | Columbia University | 2011-03-01 |
| Ibuprofen and Opioid (Morphine or Diamorphine) for Acute Pain in Sickle Cell Disease - Sickle With Ibuprofen & Morphine (NCT00880373) | London North West Healthcare NHS Trust | 2011-03-01 |
| Microvascular and Cardiac Dysfunction in Paroxysmal Nocturnal Hemoglobinuria and Sickle Cell Disease (NCT01294891) | Oregon Health and Science University | 2011-02-01 |
| Study of Vitamin D in Children With Sickle Cell Disease (NCT01276587) | Gary M Brittenham, MD | 2011-01-01 |
| Study of Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (NCT01316549) | University of California, San Francisco | 2011-01-01 |
| Intravenous Magnesium for Sickle Cell Vasoocclusive Crisis (NCT01197417) | Medical College of Wisconsin | 2010-12-01 |
| MACS Study - Microparticles and Coagulation in Sickle Cell Disease (NCT01242878) | University College, London | 2010-12-01 |
| Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease (NCT01245179) | Abdullah Kutlar | 2010-11-01 |
| A Randomized Trial of LOVAZA in Pediatric Sickle Cell Disease (SCD) (NCT01202812) | Thomas Jefferson University | 2010-10-01 |
| Genes Influencing Iron Overload State (NCT01158794) | St. Jude Children's Research Hospital | 2010-09-21 |
| Trial of Zileuton CR in Children and Adults With Sickle Cell Disease (NCT01136941) | Children's Hospital Medical Center, Cincinnati | 2010-09-01 |
| A Reduced Toxicity Allogeneic Unrelated Donor Stem Cell Transplantation (SCT) for Severe Sickle Cell Disease (NCT01279616) | Nationwide Children's Hospital | 2010-09-01 |
| Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation (NCT01319851) | Emory University | 2010-09-01 |
| Regional Anesthesia for Sickle Cell Crisis Using Ultrasound in The Emergency Department: Phase I (NCT01256281) | Icahn School of Medicine at Mount Sinai | 2010-09-01 |
| Albuminuria Reduction With Renin Angiotensin System Inhibitors in SCA Patients (NCT01195818) | Assistance Publique - Hôpitaux de Paris | 2010-09-01 |
| Propanolol and Red Cell Adhesion Non-asthmatic Children Sickle Cell Disease (NCT02012777) | University of Miami | 2010-06-01 |
| Angiotensin-converting Enzyme Inhibitors and Early Sickle Cell Renal Disease in Children (NCT01096121) | Assistance Publique - Hôpitaux de Paris | 2010-06-01 |
| Nitric Oxide Therapy for Acute Chest Syndrome in Sickle Cell Disease Children (NCT01089439) | Assistance Publique - Hôpitaux de Paris | 2010-06-01 |
| Study of Propranolol as Anti-Adhesive Therapy in Sickle Cell Disease (SCD) (NCT01077921) | Laura M. De Castro, MD | 2010-06-01 |
| Choosing Opioid Management for Pain and Analyzing Acute Chest Syndrome (ACS) Rates Equally (NCT01380197) | Children's Healthcare of Atlanta | 2010-05-26 |
| Study of an Intervention to Improve Problem List Accuracy and Use (NCT01105923) | Brigham and Women's Hospital | 2010-05-01 |
| The Brigance Assessment Of Individual Neurodevelopment In Young Children With Sickle Cell Disease- 2 (NCT01123863) | St. Jude Children's Research Hospital | 2010-05-01 |
| Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell Disease (NCT01085201) | Dana-Farber Cancer Institute | 2010-04-01 |
| Multi-Center Study of Iron Overload: Survey Study (MCSIO) (NCT01913548) | UCSF Benioff Children's Hospital Oakland | 2010-03-31 |
| Spectralis HRA+OCT Imaging of the Retina With Autofluorescence in Sickle Cell Disease (NCT01123369) | Medical University of South Carolina | 2010-02-01 |
| Epidemiology and Pathophysiological Mechanisms of HTAP in SS and SC Children in Martinique and Guadeloupe. (NCT03368261) | Centre Hospitalier Universitaire de la Guadeloupe | 2010-01-11 |
| Psychometric Evaluation of the IPPAQ in Pediatric Patients With Sickle Cell Disease Hospitalized With Vasoocclusive Pain (NCT01058473) | Connecticut Children's Medical Center | 2010-01-01 |
| A 3-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients (NCT01220115) | Novartis | 2010-01-01 |
| THE IMPROVE TRIAL: Improving Pain Management and Outcomes With Various Strategies of Patient-Controlled Analgesia (PCA) (NCT00999245) | Carelon Research | 2010-01-01 |
| Safety and Efficacy of Sodium Nitrite in Sickle Cell Disease (NCT01033227) | Children's Hospital Los Angeles | 2009-12-01 |
| Iron Mediated Vascular Disease in Sickle Cell Anemia Patients (NCT01239901) | Children's Hospital Los Angeles | 2009-12-01 |
| Multi-Center Study of Iron Overload: Pilot Study (NCT01114776) | UCSF Benioff Children's Hospital Oakland | 2009-11-01 |
| Efficacy of Vorinostat to Induce Fetal Hemoglobin in Sickle Cell Disease (NCT01000155) | Dana-Farber Cancer Institute | 2009-10-01 |
| Preventing Acute Chest Syndrome by Transfusion Feasibility Study (NCT00951808) | Carelon Research | 2009-07-01 |
| Inflammatory Response to Hydroxyurea Therapy in Sickle Cell Disease (NCT00784082) | Assistance Publique - Hôpitaux de Paris | 2009-05-01 |
| Study of Intravenous GMI-1070 in Adults With Sickle Cell Disease (NCT00911495) | GlycoMimetics Incorporated | 2009-05-01 |
| Screening Patients With Sickle Cell Disease for Kidney Damage (NCT02239016) | Children's Hospital Medical Center, Cincinnati | 2009-04-01 |
| Cardiovascular Complications of Sickle Cell Disease (NCT01044901) | University of Chicago | 2009-03-01 |
| Glutamine Therapy for Hemolysis-Associated Pulmonary Hypertension (NCT01048905) | UCSF Benioff Children's Hospital Oakland | 2009-03-01 |
| Long Term Effects of Erythrocyte Lysis (NCT00842621) | St. Jude Children's Research Hospital | 2009-03-01 |
| Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs (NCT00957931) | Stanford University | 2009-03-01 |
| Phase 1/2 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HQK-1001 Administered Daily in Patients With Sickle Cell Disease (NCT00842088) | HemaQuest Pharmaceuticals Inc. | 2009-03-01 |
| High Dose Vitamin D for Sickle Cell Disease (NCT01331148) | Wake Forest University Health Sciences | 2009-02-01 |
| Sickle Cell Disease Conditioning for Bone Marrow Transplant (NCT00968162) | Emory University | 2009-02-01 |
| Iron Overload and Growth Velocity in Thalassemia and Sickle Cell Anemia (NCT00972231) | HaEmek Medical Center, Israel | 2009-01-01 |
| European Sickle Cell Disease Cohort - Hydroxyurea (NCT02516579) | Theravia | 2009-01-01 |
| A Safety Study of Eptifibatide in Patients With Sickle Cell Disease (NCT00834899) | University of North Carolina, Chapel Hill | 2009-01-01 |
| HSCT For Patients With High Risk Hemoglobinopathies Using Reduced Intensity (NCT02435901) | Northwell Health | 2008-12-01 |